Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AGL · against 1,216 other Healthcare companies
Ranked #458 of 1,217 · scores higher than 62% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including AGL · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | AGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 0.3% | 6.1% | 32% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 22.9% | 5.8% | 83% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 458 | 8.2B CNY (≈$1.2B) | 62 | 50 | |
| 458 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 2.05T KRW (≈$1.5B) |
| 62 |
| 81 |
| 458 | 3.9B CNY (≈$549M) | 62 | 61 |
| 458 | 272M HKD (≈$35M) | 62 | 59 |
| 458 | 1.5B USD | 62 | 26 |
| 458 | 6.1B CHF (≈$7.0B) | 62 | 58 |
| 458 | 40.2B MXN (≈$2.2B) | 62 | 71 |
| 458 | 221M USD | 62 | 33 |
| 458 | 639M AUD (≈$422M) | 62 | 55 |